Last reviewed · How we verify
NCT00483236
Prospective Study Looking at Quality of Life Measures in Non-ischaemic Cardiomyopathy After Mitral Valve Repair
trial in Mitral Valve Insufficiency. Withdrawn.
1 June 2009
Quick facts
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 December 2007 |
| Primary completion | 1 June 2009 |
| Estimated completion | 1 June 2009 |
| Sites | 1 location across Canada |
Conditions studied
- Mitral Valve Insufficiency — all drugs for Mitral Valve Insufficiency →
- Dilated Cardiomyopathy — all drugs for Dilated Cardiomyopathy →
- Congestive Heart Failure — all drugs for Congestive Heart Failure →
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Who can join
Adults 21 to 80, any sex, with Mitral Valve Insufficiency or Dilated Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
* Chronic severe mitral regurgitation can lead to symptoms and left ventricular dysfunction. * The purpose of this study is to prospectively follow patients with non-ischaemic cardiomyopathy who are eligible for mitral valve repair surgery and primarily measure the quality of life through the Minnesota Living with Heart Failure Questionnaire \& the Kansas City Cardiomyopathy Questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT00483236
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mitral Valve Insufficiency
Currently open trials in the same condition.
- NCT06757049 — Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population · recruiting
- NCT06235385 — European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study · recruiting
- NCT05927441 — DragonFly EU Pivotal Study · NA · recruiting
- NCT04343313 — The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study · NA · recruiting
- NCT04153292 — The ENCIRCLE Trial · NA · recruiting
Other McGill University Health Centre/Research Institute of the McGill University Health Centre trials
Trials by the same sponsor.
- NCT07439406 — Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy · Phase 2 · not yet recruiting
- NCT07328971 — Vancomycin Taper to Prevent Recurrent Clostridioides Difficile · Phase 3 · not yet recruiting
- NCT07556952 — Dex & Mastectomy Pain · Phase 4 · recruiting
- NCT07069582 — Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women · Phase 1 · not yet recruiting
- NCT07386171 — Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00483236 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre
- Last refreshed: 12 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00483236.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing